Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As of today (2026-09-14), Malin's share price is $6.40. Malin's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was $10.66. Hence, Malin's Price to Tangible Book Ratio of today is 0.60.
The historical rank and industry rank for Malin's Price-to-Tangible-Book or its related term are showing as below:
MLLNF's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.29 * Ranked among companies with meaningful Price-to-Tangible-Book only.
A closely related ratio is called PB Ratio. As of today, Malin's share price is $6.40. Malin's Book Value per Sharefor the quarter that ended in Dec. 2024 was $10.66. Hence, Malin's P/B Ratio of today is 0.60.
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Malin Price-to-Tangible-Book Related Terms
Malin Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Malin's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLLNF vs ZTS, UTHR, VTRS: Price-to-Tangible-Book Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Malin's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Malin Price-to-Tangible-Book vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Malin's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Malin's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Malin (MLLNF) has a Price-to-Tangible-Book of 0.60 as of Sep. 14, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Malin and its competitors.
Is Malin's Price-to-Tangible-Book too high?
Malin's current Price-to-Tangible-Book is 0.60. The Drug Manufacturers industry median Price-to-Tangible-Book is 2.29. Malin's value of 0.60 is 73.8% below this industry median. Overall, Malin has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Malin's Price-to-Tangible-Book compare to ZTS and UTHR?
Malin's Price-to-Tangible-Book of 0.60 can be compared against companies in the Drug Manufacturers industry. The industry median Price-to-Tangible-Book is 2.29. Malin's value of 0.60 is 73.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Drug Manufacturers company?
The median Price-to-Tangible-Book among Drug Manufacturers companies is 2.29, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Malin's current Price-to-Tangible-Book of 0.60 is 73.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Malin and its competitors. For the Drug Manufacturers industry, the median Price-to-Tangible-Book is 2.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Malin's current Price-to-Tangible-Book is 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Malin stock overvalued right now?
Malin (MLLNF) has a current Price-to-Tangible-Book of 0.60. The current Price-to-Tangible-Book is 0.60 and 73.8% below the Drug Manufacturers industry median of 2.29. Malin's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Malin (MLLNF), the current Price-to-Tangible-Book is 0.60 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Malin Corporation PLC is a life sciences company. Its investee companies are in science and discovery, clinical and commercial sectors. The company's approach is to create shareholder value through the selective long-term application of capital and operational expertise to private, pre-trade sale operating businesses in the life sciences industry. The company derives all of its revenue from its subsidiary. The company focuses on oncology, immunology, and genetic diseases where it believes that life science and healthcare technologies will deliver transformative treatments for patients.
17GF Score
Get the complete analysis for MLLNF
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLLNF has been successfully added to your 
